Literature DB >> 10673831

Treatment services for children with ADHD: a national perspective.

K Hoagwood1, K J Kelleher, M Feil, D M Comer.   

Abstract

OBJECTIVE: To summarize knowledge on treatment services for children and adolescents with attention-deficit hyperactivity disorder (ADHD), trends in services from 1989 to 1996, types of services provided, service mix, and barriers to care.
METHOD: A review of the literature and analyses from 2 national surveys of physician practices are presented.
RESULTS: Major shifts have occurred in stimulant prescriptions since 1989, with prescriptions now comprising three fourths of all visits to physicians by children with ADHD. Between 1989 and 1996, related services, such as health counseling, for children with ADHD increased 10-fold, and diagnostic services increased 3-fold. Provision of psychotherapy, however, decreased from 40% of pediatric visits to only 25% in the same time frame. Follow-up care also decreased from more than 90% of visits to only 75%. Family practitioners were more likely than either pediatricians or psychiatrists to prescribe stimulants and less likely to use diagnostic services, provide mental health counseling, or recommend follow-up care. About 50% of children with identified ADHD seen in real-world practice settings receive care that corresponds to guidelines of the American Academy of Child and Adolescent Psychiatry. Physicians reported significant barriers to service provision for these children, including lack of pediatric specialists, insurance obstacles, and lengthy waiting lists.
CONCLUSIONS: The trends in treatment services and physician variations in service delivery point to major gaps between the research base and clinical practice. Clinical variations may reflect training differences, unevenness in the availability of specialists and location of services, and changes in health care incentives.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673831     DOI: 10.1097/00004583-200002000-00020

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  29 in total

Review 1.  Communicating genetic risk information for common disorders in the era of genomic medicine.

Authors:  Denise M Lautenbach; Kurt D Christensen; Jeffrey A Sparks; Robert C Green
Journal:  Annu Rev Genomics Hum Genet       Date:  2013       Impact factor: 8.929

2.  Dose of Methylphenidate during Service Transition for Adults with ADHD.

Authors:  Marios Adamou; Sara Bowers
Journal:  Ther Adv Psychopharmacol       Date:  2011-06

3.  Sharing of ADHD Information between Parents and Teachers Using an EHR-Linked Application.

Authors:  Jeremy J Michel; Stephanie Mayne; Robert W Grundmeier; James P Guevara; Nathan J Blum; Thomas J Power; Emily Coffin; Jeffrey M Miller; Alexander G Fiks
Journal:  Appl Clin Inform       Date:  2018-12-19       Impact factor: 2.342

4.  Examining Organizational Factors Supporting the Adoption and Use of Evidence-Based Interventions.

Authors:  Hanni B Flaherty; Lindsay A Bornheimer; Emily Hamovitch; Elene Garay; Maria L Mini de Zitella; Mary C Acri; Mary Mckay
Journal:  Community Ment Health J       Date:  2021-01-02

Review 5.  Attention-deficit/hyperactivity disorder and telemental health.

Authors:  Nancy B Palmer; Kathleen M Myers; Ann Vander Stoep; Carolyn A McCarty; John R Geyer; Amy Desalvo
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

6.  Prevalence, incidence, and stimulant use of attention-deficit hyperactivity disorder in Taiwan, 1996-2005: a national population-based study.

Authors:  I-Chia Chien; Ching-Heng Lin; Yiing-Jenq Chou; Pesus Chou
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-04-04       Impact factor: 4.328

7.  Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.

Authors:  Kathleen Ries Merikangas; Jian-Ping He; Debra Brody; Prudence W Fisher; Karen Bourdon; Doreen S Koretz
Journal:  Pediatrics       Date:  2009-12-14       Impact factor: 7.124

8.  Healthcare use by children with attention deficit/hyperactivity disorder with and without psychiatric comorbidities.

Authors:  Lynn L DeBar; Frances L Lynch; Myde Boles
Journal:  J Behav Health Serv Res       Date:  2004 Jul-Sep       Impact factor: 1.505

9.  Environmental enrichment during development decreases intravenous self-administration of methylphenidate at low unit doses in rats.

Authors:  Kristin M Alvers; Julie A Marusich; Cassandra D Gipson; Joshua S Beckmann; Michael T Bardo
Journal:  Behav Pharmacol       Date:  2012-10       Impact factor: 2.293

10.  Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands.

Authors:  Adrianne Faber; Luuk J Kalverdijk; Lolkje T W de Jong-van den Berg; Jacqueline G Hugtenburg; Ruud B Minderaa; Hilde Tobi
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-11-06       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.